German To Buy 300-Million-Euro Stake In Vaccine Developer CureVac
BERLIN, June 16 (NNN-AGENCIES) – The German government intends to invest 300 million euros (338 million U.S. dollars) in local biotechnology company CureVac, the country’s Ministry of Economic Affairs and Energy announced here on Monday.
The investment aims to support further, development of the German company and its projects in the pipeline, according to a joint statement by CureVac and the ministry. CureVac is currently developing a coronavirus vaccine.